Gastroenterology
Volume 137, Issue 5 , Pages 1641-1648.e2 , November 2009

Early Helicobacter pylori Eradication Decreases Risk of Gastric Cancer in Patients With Peptic Ulcer Disease

  • Chun–Ying Wu

      Affiliations

    • Division of Gastroenterology, Taichung Veterans General Hospital, Taichung, Taiwan
    • Department of Public Health, College of Public Health, China Medical University, Taichung, Taiwan
    • Faculty of Medicine, School of Medicine, National Yang–Ming University, Taipei, Taiwan
    • ,
  • Ken N. Kuo

      Affiliations

    • Center for Health Policy Research and Development, National Health Research Institutes; Miaoli, Taiwan
    • ,
  • Ming–Shiang Wu

      Affiliations

    • Division of Gastroenterology, National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Yi–Ju Chen

      Affiliations

    • Faculty of Medicine, School of Medicine, National Yang–Ming University, Taipei, Taiwan
    • Department of Dermatology, Taichung Veterans General Hospital, Taichung, Taiwan
    • ,
  • Chang–Bi Wang

      Affiliations

    • Division of Gastroenterology, Taichung Veterans General Hospital, Taichung, Taiwan
    • ,
  • Jaw–Town Lin

      Affiliations

    • Division of Gastroenterology, National Taiwan University Hospital, Taipei, Taiwan
    • Department of Internal Medicine, E–Da Hospital and I–Shou University, Kaohsiung County, Taiwan
    • Corresponding Author InformationReprint requests Jaw–Town Lin, MD, PhD, Department of Internal Medicine, E-Da Hospital and I-Shou University, No. 1, E-Da Rd, Jiau-Shu Tsuen, Yan-Chau Shiang, Kaohsiung County 824, Taiwan. fax: (88) 6-2-239 47899 or Chun–Ying Wu, MD, MPH, PhD, Division of Gastroenterology, Taichung Veterans General Hospital, 160, Sec. 3, Taichung–Kang Rd, Taichung 407, Taiwan. fax: (88) 6-4-23741331

Received 7 April 2009 ,Accepted 28 July 2009.

References 

  1. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest. 2007;117:60–69
  2. Wu MS, Chen CJ, Lin JT. Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1878–1882
  3. Fock KM, Talley N, Moayyedi P, et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol. 2008;23:351–365
  4. Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol. 2008;103:510–514
  5. Hunt RH. Will eradication of Helicobacter pylori infection influence the risk of gastric cancer?. Am J Med. 2004;117:S86–S91
  6. Honda S, Fujioka T, Tokieda M, et al. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res. 1998;58:4255–4259
  7. Watanabe T, Tada M, Nagai H, et al. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology. 1998;115:642–648
  8. Sugiyama A, Maruta F, Ikeno T, et al. Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res. 1998;58:2067–2069
  9. Nozaki K, Shimizu N, Ikehara Y, et al. Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci. 2003;94:235–239
  10. Lee CW, Rickman B, Rogers AB, et al. Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res. 2008;68:3540–3548
  11. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–789
  12. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004;291:187–194
  13. You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst. 2006;98:974–983
  14. Zhou LY, Lin SR, Ding SG, et al. The changing trends of the incidence of gastric cancer after Helicobacter pylori eradication in Shandong area. Chin J Dig Dis. 2005;6:114–115
  15. Leung WK, Lin SR, Ching JY, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut. 2004;53:1244–1249
  16. Mera R, Fontham ET, Bravo LE, et al. Long-term follow-up of patients treated for Helicobacter pylori infection. Gut. 2005;54:1536–1540
  17. Fuccio L, Zagari RM, Minardi ME, et al. Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther. 2007;25:133–141
  18. Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am J Gastroenterol. 2007;102:1789–1798
  19. Wu C, Wu C, Wu M, et al. Decreased hospitalization for peptic ulcer disease in Taiwan after proton pump inhibitor therapy and Helicobacter pylori eradication. Clin Gastroenterol Hepatol. 2009;7:427–431
  20. Hansson LE, Nyren O, Hsing AW, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 1996;335:242–249
  21. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392–397
  22. Take S, Mizuno M, Ishiki K, et al. The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol. 2005;100:1037–1042
  23. Gonzalez-Perez A, Garcia Rodriguez LA, Lopez-Ridaura R. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer. 2003;3:28–39
  24. Wang WH, Huang JQ, Zheng GF, et al. Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2003;95:1784–1791
  25. Wu CW, Hsieh MC, Lo SS, et al. Prognostic indicators for survival after curative resection for patients with carcinoma of the stomach. Dig Dis Sci. 1997;42:1265–1269
  26. Lee YC, Wu HM, Chen , et al. A community-based study of Helicobacter pylori therapy using the strategy of test, treat, retest, and re-treat initial treatment failures. Helicobacter. 2006;11:418–424

 This article has an accompanying continuing medical education activity on page 1837. Learning Objective: Upon completion of differentiating the following questions, successful learners will be able to increase their ability in accessing the risk of gastric cancer development and eradicating Helicobacter pylori in patients with peptic ulcer diseases.

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported in part by the National Health Research Institutes grant number: PH-098-PP-26.

PII: S0016-5085(09)01385-7

doi: 10.1053/j.gastro.2009.07.060

Gastroenterology
Volume 137, Issue 5 , Pages 1641-1648.e2 , November 2009

Article Tools

* Image Usage & Resolution